Breaking News
November 19, 2017 - Dental filling failure linked to smoking, drinking and genetics
November 19, 2017 - Medicaid expansion takes a bite out of medical debt
November 19, 2017 - Study aims to involve parents in early intervention services for children with autism
November 19, 2017 - Don’t Fret Delays in Treating Colon Cancer, Study Suggests
November 19, 2017 - Yeast Infection Test: MedlinePlus Lab Test Information
November 19, 2017 - Video of blood clot contraction reveals how platelets naturally form unobtrusive clots
November 19, 2017 - UNN researchers explore modeling of cognitive dissonance phenomenon
November 19, 2017 - Verseon presents second anticoagulation candidate for clinical trials at AHA 2017
November 19, 2017 - Pregnant Asian women who develop high blood pressure at highest risk for heart failure hospitalization
November 19, 2017 - Medicare seeks comment on ways to cut costs of Part D drugs
November 19, 2017 - Tree cover linked to fewer asthma cases in polluted urban neighborhoods
November 19, 2017 - Make the Diagnosis: Hair Care Conundrum
November 19, 2017 - New techniques give blood biopsies greater promise
November 19, 2017 - Researchers identify possible genetic basis for coronary artery disease
November 19, 2017 - Stress experienced by emergency call handlers has negative impact on psychological health
November 18, 2017 - New cancer cell screening is improving childhood leukaemia treatment
November 18, 2017 - Groundbreaking study identifies protein as potential factor in cancer metastasis
November 18, 2017 - New model to test effectiveness of existing and potential CF therapies
November 18, 2017 - Staying Active May Lower Odds for Glaucoma
November 18, 2017 - Potential new autism drug shows promise in mice
November 18, 2017 - Some states roll back ‘retroactive Medicaid,’ a buffer for the poor — and for hospitals
November 18, 2017 - Selectively deleting stem cell factor promotes recovery after TBI in mice
November 18, 2017 - Breakthrough research brings new procedure closer to helping patients with blood cancer
November 18, 2017 - Dr Peter Simpson Appointed to SLAS Board of Directors
November 18, 2017 - Friendships between young children can protect against ADHD
November 18, 2017 - Old World monkeys could hold key to stop progression of rheumatoid arthritis
November 18, 2017 - Harris Health System RNs named among 20 Outstanding Nurses for 2017
November 18, 2017 - Old World monkeys could be key to a new, powerful rheumatoid arthritis therapy
November 18, 2017 - Mount Sinai researchers identify new therapeutic target for ER+ breast cancer
November 18, 2017 - Age, CRP levels predict success in tapering of biologics in rheumatoid arthritis patients
November 18, 2017 - New dye could be used to observe electrical activity of neurons in the brain
November 18, 2017 - New study further validates use of vaginal progesterone to decrease risk of preterm birth
November 18, 2017 - Russian researcher determined range of reference values for boron in the human body
November 18, 2017 - ‘What the Health?’ Tax bill or health bill?
November 18, 2017 - Could Your Cat Give You ‘Bird Flu?’
November 18, 2017 - Vitamin D Linked to Fertility Outcomes in ART
November 18, 2017 - Neuroscientists identify genetic changes in microglia in a mouse model of neurodegeneration and Alzheimer’s disease
November 18, 2017 - Tax reform proposal could impact care for older Americans
November 18, 2017 - PCSK9 inhibitor offers clinical benefit to patients with peripheral artery disease
November 18, 2017 - Researchers receive £1.3 million to develop sight-saving imaging technology
November 18, 2017 - Novel buckypaper sensor could pave way for high-performance, affordable wearable technology
November 18, 2017 - Despite ACA cost protections, most adolescents skip regular checkups
November 18, 2017 - Stem cell treatment allows paraplegic rats to walk and regain sensory perception
November 18, 2017 - HTC analytical conference comes to the UK
November 18, 2017 - Face It: Drinking, Smoking Takes Toll on Looks: MedlinePlus Health News
November 18, 2017 - New research shows where in the brain the earliest signs of Alzheimer’s occur
November 18, 2017 - Philips announces launch of global movement to raise awareness for COPD
November 18, 2017 - University of Bristol awarded grant to reduce antibacterial drug resistance in Thailand
November 18, 2017 - New oxytocin chemical sensor could be first step towards early diagnosis of autism
November 18, 2017 - Study shows how naïve T-cells may affect tumor immunity and immunotherapy
November 18, 2017 - New studies highlight importance of cardiorespiratory fitness to reduce CVD risk
November 18, 2017 - Study finds medical cannabis is effective at reducing opioid addiction
November 18, 2017 - Specially tailored, ultrafast light pulses can trigger neurons to fire in different patterns
November 18, 2017 - Decrease in sunshine linked to rising incidence of Rickets
November 18, 2017 - Harnessing social media big data to fight against prescription drug crisis
November 18, 2017 - Researchers find way to switch tumor cells between 2D and 3D morphology
November 18, 2017 - Leaf-eating ability of beetle largely due to bacteria inside the insect
November 18, 2017 - FDA Approves Hemlibra (emicizumab-kxwh) for Hemophilia A with Inhibitors
November 18, 2017 - Adolescents underreport amphetamine use, likely unaware that adderall is amphetamine
November 18, 2017 - Study reveals a reduced risk of teenage eczema in breastfed babies
November 18, 2017 - Separating side effects could pave way for safe, effective pain medications
November 18, 2017 - Gut bacteria at young age can contribute to MS disease onset and progression, study suggests
November 18, 2017 - Environmental triggers may play role in development of Lupus
November 18, 2017 - Review looks into conventional versus new treatment modalities in orthodontic pain management
November 17, 2017 - FDA Alert: Diphenoxylate Hydrochloride and Atropine Sulfate Tablets by Greenstone: Recall
November 17, 2017 - For older women, every movement matters
November 17, 2017 - Talking-based therapy could transform aftercare for cancer survivors
November 17, 2017 - Olympus IXplore SpinSR10 imaging system enables researchers to observe fine details in live cells
November 17, 2017 - Study explores reasons for underrepresentation of minorities in genetic cancer research
November 17, 2017 - California firm running physician practices is closing down as scrutiny ramps up
November 17, 2017 - BMI not valid measure of obesity in postmenopausal women, study shows
November 17, 2017 - Vaginal progesterone decreases the risk of premature birth in women with short cervix
November 17, 2017 - Pricey ER Tests for Chest Pain Often Unnecessary
November 17, 2017 - ‘Old’ Lungs May Be Good Transplant Options: MedlinePlus Health News
November 17, 2017 - How not to gain weight over the holidays
November 17, 2017 - Researchers map first-ever proteome of healthy human heart
November 17, 2017 - Drug used to prevent and treat malaria may also be effective for Zika virus
November 17, 2017 - One in 20 children still receiving codeine to treat pain despite warning from federal regulators
November 17, 2017 - Improving clinical trials with machine learning
November 17, 2017 - Experts identify mental exercise program that can reduce risk of dementia
Novel CV Risk Marker in RA Identified

Novel CV Risk Marker in RA Identified

image_pdfDownload PDFimage_print

Action Points

  • Anti-citrullinated fibrinogen (anti-cit-fibrinogen) may serve as a potential biomarker for assessing cardiovascular (CV) risk in patients with rheumatoid arthritis (RA).
  • Note that the study suggests that anti-cit-fibrinogens can improve CV risk stratification in RA patients.

Anti-citrullinated fibrinogen (anti-cit-fibrinogen) may serve as a potential biomarker for assessing cardiovascular (CV) risk in patients with rheumatoid arthritis (RA).

In examining 10 types of anti-cit-fibrinogens in patients with RA, anti-cit-fibrinogens as a group were associated with coronary artery disease (CAD) outcomes, with the association driven by a subset of autoantibodies in a subgroup that contained seven of the 10 anti-cit-fibrinogens, found researchers from Boston and Bordeaux, France.

Boris P. Hejblum, PhD, of Harvard School of Public Health in Boston, and the University of Bordeaux in France, and colleagues wrote that their study supports preclinical data and suggests that anti-cit-fibrinogens can improve CV risk stratification in RA patients.

“While our study adjusted for traditional CV risk factors, future Phase 4 biomarker development studies investigating the predictive value of these biomarkers in an independent cohort are needed,” they wrote in Arthritis Care & Research.

CV disease is the leading cause of death for patients with RA. Traditional risk factors tend to underestimate CV risk in patients with RA. A specific class of anti-citrullinated proteins antibodies (ACPAs), anti-cit-fibrinogen, have been studied as a potential marker for CV disease in RA, with research to suggest “a mechanistic pathway whereby inflammation promoted cit-fibrinogen in atherosclerotic plaques, and thus the development of anti-cit-fibrinogen may be a useful marker of inflammation, atherosclerotic burden and CV risk in RA,” Hejblum and colleagues wrote. A subsequent study that used a different platform to measure anti-cit-fibrinogen, however, failed to detect an association between carotid intima media thickness and anti-cit-fibrinogen titers.

These previous studies examined surrogate CV outcomes, prompting the authors to examine the association between ACPAs and CAD outcomes in a cohort of 1,006 patients with RA from two large tertiary care hospitals. Plasma samples from patients were measured for anti-cit-fibrinogen. Antibodies directed against 10 epitopes of cit-fibrinogen were measured.

The mean age of the patients was 61.0 years; 79.0% were female, and 72.2% were positive for anti-cyclic citrullinated peptide (CCP).

A principal components analysis (PCA) was performed to assess whether the anti-cit-fibrinogens clustered into groups, and each group was tested for its association with CAD.

From the PCA analysis, three main groups emerged: PC1, PC2, and PC3. PC1 accounted for more than 80% of the anti-cit-fibrinogen antibody variability among all anti-cit-fibrinogen antibodies. PC2 explained an additional 7.7% of variability; and PC3, an additional 3.5% of variability.

As a group, the anti-cit-fibrinogens were associated with a higher risk of CAD, adjusted for age, gender, race, diabetes, hypertension, hyperlipidemia, smoking, and use of non-biologic disease-modifying antirheumatic drugs (DMARDs), biologic DMARDs, and prednisone (P=0.00011). By subgroup, the strongest association was observed in group PC2, which included seven of the 10 anti-cit-fibrinogens examined (P=0.015).

A sensitivity analysis using ICD9 codes showed a similar association between anti-cit-fibrinogen as a group with ischemic heart disease (P=0.00029), as well as between-group PC2 and ischemic heart disease (P=0.004). Using the same covariates for adjustment, no association between anti-CCP positivity and CAD was observed (OR 1.3, 95% CI 0.7-2.3).

A total of 897 RA patients had high-sensitivity C-reactive protein (hsCRP) data recorded. The association between anti-cit fibrinogens and CAD remained significant, adjusting for CV risk factors and hsCRP (P=0.00022 among overall cohort, P=0.0071 for group PC2). This association remained significant after adjusting the model to include hsCRP and anti-CCP status. The concentrations of anti-cit fibrinogen therefore provided information additional to anti-CCP in identifying which RA patients had CAD, Hejblum and colleagues said.

They added that the study may explain why some previous reports did not find associations between anti-cit-fibrinogen and surrogate measures of CV risk: “While we detected a significant association between all anti-cit-fibrinogens with CAD, the signal appeared to be driven by a group of targets within the large fibrinogen molecule. Thus, if a particular ACPA assay does not measure antibodies targeting specific regions of fibrinogen, an association with CAD, may not be detected.”

A limitation to the study, the team noted, was the collection of samples in patients with prevalent CAD, thus not permitting an estimation of the value of anti-cit-fibrinogen in predicting future CAD risk.

Funding was provided by the Rheumatology Research Foundation.

  • Reviewed by
    Robert Jasmer, MD Associate Clinical Professor of Medicine, University of California, San Francisco and Dorothy Caputo, MA, BSN, RN, Nurse Planner

1969-12-31T19:00:00-0500

last updated

Tagged with:

About author

Related Articles